suMMARY An ELISA method was developed for the measurement of toxoplasma IgG antibodies in human serum using antigen-coated polystyrene beads as a solid phase and anti human IgG-horse radish peroxidase conjugate as an enzymatic tracer. In order to assess ELISA sensitivity and specificity, a between methods comparison was made using 'conventional' serological tests as reference (dye-test, crossover-linked immunoassay, passive haemagglutination, indirect immunofluorescence). From an analysis of the group classifications obtained some considerations emerged: the ELISA specificity looks comparable with that of the 'reference' tests, as no sample classified as negative by all these tests was ELISA-positive, and vice versa; ELISA appears to correlate better with haemagglutination and immunofluorescence, on the basis of the respective class frequencies; in particular, the number of positives, which is much lower for the dye-test and crossover-linked immunoassay, suggests that a higher sensitivity is reached in the former cases.
None of the several tests mostly used for the serodiagnosis of toxoplasmosis appears fully adequate for mass-screening purposes as far as analytical reliability, experimental ease, and promptness of response are concerned. As a matter of fact some of them need special equipment not widely available, and others cannot be used as single tests owing to the incompleteness of the information obtainable and the poor correlation with the clinical situation.
Recently, the enzyme-linked immunosorbent assay (ELISA) has been proposed as a promising serological test for infective and infestive diseases. '-5 Also in our laboratories attempts were made to evaluate the actual potential of ELISA in the diagnosis of toxoplasma infections. In particular, this study was aimed at defining the specificity and sensitivity of an ELISA method we have recently developed through a comparison with other serological tests assumed as references, such as the dyetest, crossover-linked immunoassay, indirect haemagglutination, and indirect immunofluorescence.
Received for publication 6 December 1979 Material and methods
SAMPLES
The samples were taken at random among human sera sent for toxoplasma serodiagnosis to diagnostic centres in Milan.
ELISA REAGENTS AND PROCEDURE Antigen Soluble extracts from throfozoites of Toxoplasma gondii, RH strain, harvested from the peritoneal exudate of mice 72 hours after injection, were prepared by sonication disruption of cells, followed by centrifugation. A solution of 10 ,/g protein/ml in Tris-HCl buffer, pH 7-2, was used for coating.
Solid phase Polystyrene beads, ca 6 mm diameter (Precision Plastic Balls, USA), were sensitised through overnight immersion in the coating solution at room temperature, followed by washing with deionised water and vacuum-drying.
ELISA for toxoplasma antibody detection: a comparison with other serodiagnostic tests Enzyme-labelled anti human globulins Horse radish peroxidase (HRP, Boehringer, FRG) and rabbit anti human IgG, purified by affinity chromatography, were coupled using the periodate method6 slightly modified to obtain an approximate HRP/IgG molar ratio of 2. The conjugate was purified through gel-filtration on Sephadex G-200 (Pharmacia, Sweden) and used in the assay at a dilution of approximately 0-4 ,ug/ml in 0-05 M phosphate buffer, pH 7-4, containing 4% bovine serum albumin (BSA) and 0-01 % merthiolate.
Substrate for the enzymatic reaction 150 mg of O-phenylene-diamine dihydrochloride (home-prepared from the free base) were added before use to 50 ml of 0-25 M phosphate-citrate buffer containing 0-02% H202, to obtain a final pH of 4-8.
Diluent system for serum samples 0-05 M phosphate buffered saline, pH 7-4, 4 % BSA, 0-01 M EDTA, 0-1 % NaN3, was used.
ELISA procedure
The following scheme was adopted: Tables 1 and 2, respectively. The latter table shows that 16 samples are classified as negative and 12 as positive by all the reference methods ('reliably' negative and 'reliably' positive). The 16 reliably negative samples gave in the ELISA system a mean value and an SD of 126 ± 17-5 mU. Therefore, assuming a 1 %o probability of misclassification (ie, x + 4 SD), the upper limit for the negative population is 196 mU. For the 12 reliably positive samples mean and SD were 469 ± 124 mU. This corresponds to a distribution ranging, at a 95% probability (x-2 SD to R + 2 SD), from 221 to 717 mU without any overlap with the negative class.
From an analysis of the ELISA data, imposing the 196 mU limit for the negative population, 25 out of 86 samples were negative. A comparison of these results with those given by the other methods (Table  3 ) demonstrated that (a) no ELISA negative sample was classified as positive by any other method, and (b) nine negatives were seen as borderline by one or two reference methods (ie, 5 IF, 2HA, and 2 cLIA borderlines).
Taking into account all the reference tests combined together, no 'reliably' borderline population can be identified (Table 2) . Therefore, to complete DT  25  0  0  cLIA  23  2  0  HA  23  2  0  IF  20  5  0 the evaluation, the tests were grouped according to their stated levels of sensitivity. In this way 20 borderline samples resulted, combining HA and IF tests. This population gave mean and SD ELISA values of 299 ± 49 mU, corresponding to a distribution ranging, at a 95% probability, from 201 to 397 mU. It is apparent that this population is completely discriminated from the negative one, while some overlap exists with the positive class. A range for the borderline samples could be tentatively assumed to be 200-350 mU (ie, from the negativeborderline cut-off to x + SD where x refers to the mean ELISA response of HA-IF borderlines). By applying the same analysis to the 16 samples classified as borderline by DT and cLIA, a mean value of 374 + 77 mU and a 95 % probability range 220-528 were obtained. Also in this case no overlap with the negative population can be observed, but borderlines and positives largely superimpose.
The classification of the 86 samples according to the ELISA response is shown in Table 4 The ELISA conditions adopted were directed to obtain a high practicability level rather than to exploit the full potential of the method. Work is presently in progress to optimise further the ELISA performances as for sensitivity (incubation time, sample dilution), response precision, and consistency (reagent stability, way of expressing data), and, especially, possibility of discriminating between IgG and IgM antibody classes.
